Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib mesylate in Nephrogenic Systemic Fibrosis
NCT00677092Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in nephrogenic systemic fibrosis (NSF), sponsored by Massachusetts General Hospital. Started Dec 2007; status: completed.
02
Drugs
03
Conditions
nephrogenic systemic fibrosis (NSF)
Beyond the preview
Go deeper on NCT00677092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00677092.